The U.S. Food and Drug Administration is approving Eraxis to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems.
Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research, says, "This product offers a new alternative therapy for several types of infections associated with Candida
